Article
SUVmax and Tumour Location in PET-CT Predict Oncogene Status in Lung Cancer.
Oncology research and treatment - 1 Jan 2016
Putora Paul M, Szentesi Kinga, Glatzer Markus, Rodriguez Regulo, Müller Joachim, Baty Florent, Früh Martin
Abstract excerpt
BACKGROUND: In non-small cell lung cancer, anaplastic lymphoma kinase gene rearrangement (ALK+) and epidermal growth factor receptor mutations (EGFR+) are targetable with tyrosine kinase inhibitors. PATIENTS AND METHODS: 27 patients with ALK+ tumours, who underwent positron emission tomography-computed tomography (PET-CT) prior to any treatment, were identified. 2 equally sized control groups based on consecutive...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
